CRINETICS PHARMACEUTIC
59.81
07-November-24 15:59:58
15 minutes delayed
Stocks
+0.65
+1.10%
Today's range
58.66 - 60.17
ISIN
N/A
Source
NASDAQ
-
Crinetics Pharmaceuticals Provides Update on CRN04777 Program
28 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
22 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
14 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Nov 2022 16:30:43 By Nasdaq GlobeNewswire
-
13 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Oct 2022 16:57:25 By Nasdaq GlobeNewswire
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
06 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
03 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
08 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
06 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
02 Sep 2022 08:00:00 By Nasdaq GlobeNewswire
-
12 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Aug 2022 16:44:12 By Nasdaq GlobeNewswire
-
04 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Jul 2022 17:09:22 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2022 16:30:47 By Nasdaq GlobeNewswire
-
Crinetics Presents Clinical and Research Results at ENDO 2022
08 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
07 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
25 May 2022 07:00:00 By Nasdaq GlobeNewswire